Unveiling Advanced In Vivo Efficacy Models
Join an exciting upcoming webinar where you'll explore how in vivo pharmacokinetic (PK) and pharmacodynamic (PD) efficacy models are revolutionizing fields such as oncology, immunology, and fibrosis. Participants will have the chance to learn from real-world case studies that showcase the successful implementation of these models, gaining insight into the latest trends in methodology.
Importance of Efficacy Models in Drug Development
The role of a comprehensive suite of in vivo services is vital in understanding drug behavior, efficacy, and safety. This webinar will discuss how enhanced PK/PD and efficacy models can streamline the journey of drug candidates from the initial discovery phase to the preclinical development stage.
Case Studies: Real-World Applications
The seminar will focus on three essential therapeutic domains — oncology, immuno-oncology, and fibrosis. By presenting both internal and customer-verified case studies, it will illuminate how preclinical in vivo platforms have significantly influenced decision-making and expedited program timelines. Through these examples, the increasing demand for predictive and scalable preclinical models will be emphasized.
Developing Disease-Relevant Models
This session will analyze how both validated and tailored in vivo platforms are instrumental in creating disease-relevant models that closely mirror human pathophysiology. The integration of PK/PD studies with biomarker assessments is crucial in confirming mechanisms of action. Moreover, the webinar highlights that study designs are meticulously crafted to align with clinical and regulatory aspirations.
Innovative Approaches for Enhanced Insights
Using advanced analytics such as digital histopathology offers quantifiable insights into research processes, enabling a collaborative approach that effectively guides progress towards IND-enabling milestones.
Register to Learn More
Discover how these in vivo efficacy models can speed up preclinical success across various therapeutic areas, including oncology and immunology. Secure your spot for this insightful event!
Expert Contributions
The webinar will feature insights from distinguished experts, including Malavika Ghosh, PhD, Senior VP, and Head of Global Preclinical Research Services; and Linh Nguyen, PhD, Director of Oncology & Immunology at Aragen Bioscience.
Join Us Live
The live session will take place at 11 am EDT, offering a convenient opportunity for global participants to engage with industry leaders.
Frequently Asked Questions
What is the focus of the upcoming webinar?
The webinar will focus on how advanced in vivo PK/PD and efficacy models enhance drug development in oncology, immunology, and fibrosis.
Who are the speakers for the webinar?
Experts, including Malavika Ghosh and Linh Nguyen from Aragen Bioscience, will present their insights and experiences.
When will the webinar be held?
The live webinar is scheduled for 11 am EDT on the designated day.
How can I register for the webinar?
Registration details will be provided during the promotional phase leading up to the webinar.
What topics will be covered in the webinar?
The seminar will cover case studies, drug development strategies, and the application of in vivo efficacy models in preclinical settings.
